Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: Results of a retrospective study of 132 patients and review of the literature

Leukemia

Volumn 14, Issue 6, 2000, Pages 1044-1051

  Rimsza, L M ^a,h   Kopecky, K J ^b   Ruschulte, J ^a   Chen, I M ^a   Slovak, M L ^c   Karanes, C ^d   Godwin, J ^e   List, A ^f   Willman, C L ^a,g  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g UNIVERSITY OF NEW MEXICO   (United States)

^h UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute myelogenous leukemia; DNA repair; Microsatellite instability; Secondary leukemia; Theraphy induced leukemia

Indexed keywords

DNA; GENE PRODUCT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BASE MISPAIRING; BLAST CELL; CANCER RECURRENCE; CAPILLARY ELECTROPHORESIS; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE;

EID: 0034123441     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401699     Document Type: Article

References (43)

1. Horwitz M, Benson K, Li F, Wolff J, Leppert M, Hobson L, Mangelsdorf M, Yu S, Hewett D, Richards R, Raskind W. Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. Am J Hum Genet 1997; 61: 873-881.
2. Ho C, Otterud B, Legare R, Varvil T, Saxena R, DeHart D, Kohler S, Aster J, Dowton S, Li F, Leppert M, Gilliland D. Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2. Blood 1996; 87: 5218-5224.
3. Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogen 1997; 93: 84-99.
4. Aaltonen LA et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
5. Thibodeau SN, Bren G, Schald D. Microsatellite instability in cancer of the proximal colon. Science 1993; 260: 816-819.
6. Fishel R, Lescoe M, Ran M, Copeland N, Jenkins N, Garber J, Kane M, Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027-1038.
7. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R, Ruschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997; 57: 4749-4756.
8. Gaidano G, Pastore C, Gloghini A, Capello D, Tirelli U, Saglio C, Carbone A. Microsatellite instability in KSHV/HHV-8 positive body-cavity-based lymphoma. Hum Pathol 1997; 28: 748-750.
9. Lowsky R, DeCoteau JF, Reitmair AH, Ichinohasama R, Dong W-F, Xu Y, Mak TW, Kadin ME, Minden MD. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic: lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL). Blood 1997; 89: 2276-2282.
10. Pabst T, Schwaller J, Jotterand Bellomo M, Oestreicher M, Muhlematter D, Tichelli A, Tobler A, Fey MF. Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood 1996; 88: 1026-1034.
11. Gartenhaus R, Johns III MM, Wang P, Rai K, Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood 1996; 87: 38-41.
12. Tasaka T, Lee S, Spira S, Takeuchi S, Nagai M, Takahara J, Koeffler HP. Microsatellite instability during the progression of acute myelocytic leukemia. Br J Haematol 1997; 98: 219-221.
13. Wada C, Shionoya S, Fujino Y, Tokuhiro H, Akahoshi T, Uchida T, Ohtani H. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood 1994; 83: 3449-3456.
14. Silly H, Chase A, Mills KI, Apfelbeck U, Sormann S, Goldman JM, Cross NCP. No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisis. Leukemia 1994; 8: 1923-1928.
15. Ohyashiki JH, Ohyashiki K, Aizawa S, Kawakubo K, Shimamoto T, Iwama H, Hayashi S, Toyama K. Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia. Clin Cancer Res 1996; 2: 1583-1589.
16. Indracollo S, Simon M, Hehlmann R, Erfle V, Chieco-Bianchi L, Leib-Moesch C. Genetic instability of a dinucleotide repeat-rich regions in three hematologic malignancies. Leukemia 1995; 9: 1517-1522.
17. Robledo M, Martinez B, Arranz E, Trujillo M, Gonzalez Ageitos A, Rivas C, Benitez J. Genetic instability of microsatellites in hematological neoplasms. Leukemia 1995; 9: 960-964.
18. Sill H, Goldman j, Cross N. Rarity of microsatellite alterations in acute myeloid leukemia. Br J Cancer 1996; 74: 255-257.
19. Tasaka T, Lee S, Spira S, Takeuchi S, Hatta Y, Nagai M, Takahara J. Infrequent microsatellite instability during the evolution of myelodysplastic syndrome to acute myelocytic leukemia. Leukemia Res 1996; 20: 113-117.
20. Boyer J, Risinger J, Farber R. Stability of microsatellites in myeloid neoplasias. Cancer Genet Cytogenet 1998; 106: 54-61.
21. Ben-Yehuda D, Krichevsky S, Caspi O, Rund D, Polliack A, Abeliovich D, Zelig O, Yahalom V, Paltiel O, Or R, Peretz T, BenNeriah S, Yehuda O, Rachmilewitz EA. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 1996: 88: 4296-4303.
22. Godwin J, Kopecky K, Head D, Willman C, Leith C, Hynes H, Balcerzak S, Applebaum F. A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (9031). Blood 1998; 91: 3607-3615.
23. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen I-M, Head DR. Appelbaum F, Willman CL. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323-3329.
24. Parsons R, Li G-M, Longley M, Modrich P, Liu B, Berk T, Hamilton SR, Kinzler K, Vogelstein B. Mismatch repair deficiency in phenotypically normal human cells. Science 1995; 268: 738-740.
25. Abrahamson G, Boultwood J, Madden J, Kelly S, Oscier DG, Rack K, Buckle VJ, Wainscoat JS. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. Br J Haematol 1991 ; 79: 550-555.
26. Culligan DJ, Cachia P, Whittaker J, Jacobs A, Padua RA. Clonal lymphocytes are detectable in only some cases of MDS. Br J Haematol 1992; 81: 346-352.
27. van Kamp H, Fibbe WE, Jansen RPM, van der Keur M, de Graaff E. Willemze R, Landegent JE. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood 1992; 80: 1774-1780.
28. Tefferi A, Thibodeau SN, Solberg Jr LA. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990; 75: 1770-1773.
29. Janssen JWG, Buschle M, Layton M, Drexler HG, Lyons J, van den Berghe H, Heimpel H, Kubanek B, Kleihauer E, Mufti GJ, Bartram CR. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood 1989; 73: 248-254.
30. Tsukamoto N, Morita K, Maehara T, Okamoto K, Karasawa M, Omine M, Naruse T. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1992; 83: 589-594.
31. Champion KM, Gilbert JGR, Asimakopoulos FA, Hinshelwood S, Green AR. Clonal haemopoiesis in normal elderly women: implications for the myeloproliterative disorders and myelodysplastic syndromes. Br J Haematol 1997; 97: 920-926.
32. Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, Maragh M, Gilliland DG. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996; 88: 59-65.
33. Hauge XY, Litt M. A study of the origin of 'shadow bands' seen when typing dinucleotide repeat polymorphisms by the PCR. Hum Molo Genet 1993; 2: 411-415.
34. Toh Y, Oki E, Oda S, Tomoda M, Tomisaki S, Ichiyoshi Y, Ohno S, Sugimachi K. An integrated microsatellite length analysis using an automated fluorescent DNA sequencer. Cancer Res 1996; 56: 2688-2691.
35. Cawkwell L, Li D, Lewis FA, Martin I, Dixon MF. Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology 1995; 109: 465-471.
36. Kaneko H, Horiike S, Inazawa I, Nakai H, Misawa S. Microsatellite instability is an early genetic event in myelodysplastic syndrome. Blood 1995; 86: 1236-1237.
37. Orazi A, Cattoretti G, Heerema N, Sozzi G, John K, Neiman R. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of hone marrow biopsies. Mod Pathol 1993; 6: 521-525.
38. Kitagawa M, Yoshida S, Kuwata T, Tanizawa T, Kamiyama R. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia. Am J Pathol 1994; 145: 338-344.
39. Jonveaux P, Fenaux P, Quiquandon J, Pignon J, Lai J, Loucheux-Lefebvre M, Goossens M, Buaters F, Berger R. Mutations in the p53 gene in myelodysplastic syndromes. Oncogene 1991; 6: 2243-2247.
40. Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia 1994; 8: 1342-1349.
41. Sugimoto K, Hirano N, Toyshima H, Chiba S, Mano H, Takaku F, Yazaki Y, Hirai H. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 1993; 8: 3022-3026.
42. Ludwig L, Schulz A, Janssen J, Grunewaki K, Bartram C. P53 mutations in myelodysplastic syndromes. Leukemia 1992; 6: 1302-1304.
43. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson KKV, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392: 300-303.